Back to search
Resectable Rectal Cancer Clinical Stage II and III
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Resectable Rectal Cancer Clinical Stage II and III trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Resectable Rectal Cancer Clinical Stage II and III trials you may qualify forThe study is being conducted to evaluate the safety and efficacy of Adebrelimab and SHR-8068 in combination with chemoradiotherapy in subjects with rectal cance…
The aim of this clinical trial is to test whether minimal residual disease (MRD) status detected by circulating tumor DNA (ctDNA) could be used to guide precisi…
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug, giving the…
RATIONALE: Drugs used in chemotherapy, such as capecitabine, fluorouracil, and oxaliplatin work in different ways to stop tumor cells from dividing so they stop…